Merck posted better-than-expected results for the first quarter on the strength of its blockbuster cancer immunotherapy Keytruda and HPV vaccine Gardasil.
-Drugmaker Merck & Co Inc on Thursday posted better-than-expected results for the first quarter on the strength of its blockbuster cancer immunotherapy Keytruda and human papillomavirus vaccine Gardasil.
The company's revenue fell year-over-year due to a sharp, but expected, drop in sales from COVID pill molnupiravir, and rose more than 10% excluding that drug. Sales for COVID treatment molnupiravir - sold under the brand name Lagevrio - fell to $392 million from $3.2 billion last year. The company has said it expects just $1 billion of molnupiravir sales this year.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Merck beats first-quarter expectations on Keytruda, Gardasil strengthDrugmaker Merck & Co Inc on Thursday posted better-than-expected results for the first quarter on the strength of its blockbuster cancer immunotherapy Keytruda and human papillomavirus (HPV) vaccine Gardasil.
Read more »
Merck stock pops premarket after Q1 earnings beatMerck & Co. Inc.’s stock rose 2% premarket Thursday, after the company posted better-than-expected first-quarter earnings and offered guidance that topped...
Read more »
Meta Platforms stock rallies on results, Mobileye Global stock sinks and other stocks on the moveCaterpillar and Merck & Co’s stock rise after reporting quarterly results.
Read more »
Merck results beat expectations despite a big drop in sales of Covid antiviral treatmentDespite the drop in molnupiravir sales, Merck's revenue and adjusted earnings for the first quarter beat Wall Street's expectations.
Read more »
Barclays beats profit expectations on credit card boom By Reuters⚠️BREAKING: *BARCLAYS BEATS Q1 PROFIT EXPECTATIONS ON CREDIT CARD BOOM; SHARES UP 4% $BARC $BCS 🇬🇧🇬🇧
Read more »
Amazon revenue beats on stable online demand, cloud strength By Reuters⚠️BREAKING: *AMAZON JUMPS 11% AFTER-HOURS FOLLOWING Q1 EARNINGS AND SALES BEAT $AMZN
Read more »